文特尔成立了用于商业用途的合成基因组学公司(SGI)，旨在解决全球性问题，如对化石燃料的依赖，环境退化和疾病流行。
Venter starts the for-profit Synthetic Genomics Inc. (SGI) to work on solving global problems, such as fossil-fuel dependence, environmental degradation and disease epidemics.
本文以风湿性疾病常用的治疗药物为主线，归纳了近年来影响药物疗效中有关药物代谢酶、药物转运体和药物作用靶点的基因组学研究进展。
The progress of pharmacogenomic research in the effects of drug treatment on rheumatic diseases could prevent adverse reactions, and provide reasonable guidance to clinical treatment.
毒理基因组学主要在基因组水平上研究机体对环境因子的应答反应，了解基因和环境交互作用在疾病发生中的作用。
Toxicogenomics mainly study the response of human body to the environmental elements, and understand the effect of gene-environment interaction to the disease in molecular level.
应用推荐